Citalopram

ATC Code N06AB04

Citalopram

Definition

A bicyclic phthalene derivative and selective serotonin reuptake inhibitor (SSRI), with antidepressant and anxiolytic activities. Citalopram selectively inhibits the neuronal reuptake of the neurotransmitter serotonin (5-HT) in presynaptic cells in the central nervous system, thereby increasing levels of 5-HT within the synaptic cleft and enhancing the actions of serotonin on its receptors. Increased serotonergic neurotransmission results in antidepressive and anxiolytic effects.

Also known as 1,3-Dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile, Cipram, CITALOPRAM, Lu 10-171, Nitalapram — per NCIT

Also identified as

Indications

Disease Relation Source
Alcohol abuse may treat MEDRT · Public domain (U.S. Government work)
Dementia may treat MEDRT · Public domain (U.S. Government work)
Depressive disorder may treat MEDRT · Public domain (U.S. Government work)
Diabetic neuropathy may treat MEDRT · Public domain (U.S. Government work)
Nicotine dependence may treat MEDRT · Public domain (U.S. Government work)
Obsessive-compulsive disorder may treat MEDRT · Public domain (U.S. Government work)

Organ Effects

Organ Side effect / interaction Source
Central nervous system may treat a disease of this organ DERIVED · CC BY 4.0
Nervous system may treat a disease of this organ DERIVED · CC BY 4.0

2 entries above are marked DERIVED: Atlas Médico inferred them by combining two sourced claims, and no source asserts these links directly. Treat them as a navigation aid, not as a clinical statement.